<- Go Home
Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Market Cap
$25.5M
Volume
57.9K
Cash and Equivalents
$1.2M
EBITDA
-$8.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$74.0K
Profit Margin
100.00%
52 Week High
$9.00
52 Week Low
$2.74
Dividend
N/A
Price / Book Value
9.16
Price / Earnings
-12.83
Price / Tangible Book Value
15.25
Enterprise Value
$24.3M
Enterprise Value / EBITDA
-2.97
Operating Income
-$8.2M
Return on Equity
832.21%
Return on Assets
-162.14
Cash and Short Term Investments
$1.2M
Debt
N/A
Equity
$2.8M
Revenue
$74.0K
Unlevered FCF
-$3.8M
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium